FH and renal cell adenocarcinoma: A large study cohort including 77 FH-deficient RCC patients observed in the real world has been reported in China (26), with a median progression time of only 21 months, among which 70 patients were confirmed with FH germline mutation and the other 7 patients confirmed with somatic mutation.